Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV-Reference-Cited by-同舟云学术

Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV

Published:2017-06-08 Issue:6 Volume:112 Page:526-534
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Custer B.¹²^ORCID,Janssen M. P.³⁴^ORCID,Hubben G.⁵,Vermeulen M.⁶,van Hulst M.⁷⁸

Affiliation:

1. Blood Systems Research Institute; San Francisco CA USA

2. Department of Laboratory Medicine; University of California San Francisco; San Francisco CA USA

3. Julius Center for Health Sciences and Primary Care; UMC Utrecht; Utrecht The Netherlands

4. Transfusion Technology Assessment Department; Sanquin Research; Sanquin Blood Supply Foundation; Amsterdam The Netherlands

5. BaseCase; Berlin Germany

6. South African National Blood Service; Johannesburg South Africa

7. Department of PharmacoTherapy, Epidemiology & Economics; University of Groningen; Groningen The Netherlands

8. Department of Clinical Pharmacy and Toxicology; Martini Hospital; Groningen The Netherlands

Funder

ISBT Transfusion Trasmitted Infectious Diseases Working Party

Grifols/Hologic

Macopharma

TerumoBCT

BioRad

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12538/fullpdf

Reference24 articles.

1. Risk-based decision-making for blood safety: preliminary report of a consensus conference;Stein;Vox Sang,2011

2. Alliance of blood operators risk-based decision-making I: health economics and outcomes methods in risk-based decision-making for blood safety;Custer;Transfusion,2015

3. Pharmaco-economics of blood transfusion safety: review of the available evidence;Hulst;Vox Sang,2002

4. Economic analyses of blood safety and transfusion medicine interventions: a systematic review;Custer;Transfus Med Rev,2004

5. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables;Baltussen;Int J Technol Assess Health Care,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks;Transfusion Medicine Reviews;2023-07

2. Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis;Vox Sanguinis;2023-05-14

3. Economic Evaluation of Nucleic Acid Testing for Screening of Blood Donations for Thalassemia Patients (ECONAT) in Western India;Indian Journal of Hematology and Blood Transfusion;2022-09-05

4. Cost‐effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogens;Transfusion;2022-05-13

5. Cost‐effectiveness and budget impact of whole blood pathogen reduction in Ghana;Transfusion;2021-10-14